摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[4-(6,7-Difluoro-quinoxalin-2-ylamino)-phenyl]-acetic acid | 476374-09-1

中文名称
——
中文别名
——
英文名称
[4-(6,7-Difluoro-quinoxalin-2-ylamino)-phenyl]-acetic acid
英文别名
——
[4-(6,7-Difluoro-quinoxalin-2-ylamino)-phenyl]-acetic acid化学式
CAS
476374-09-1
化学式
C16H11F2N3O2
mdl
——
分子量
315.279
InChiKey
VNLQJYZZNQBAJJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    512.1±50.0 °C(Predicted)
  • 密度:
    1.487±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.28
  • 重原子数:
    23.0
  • 可旋转键数:
    4.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    75.11
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [4-(6,7-Difluoro-quinoxalin-2-ylamino)-phenyl]-acetic acidsodium hydroxide氰基磷酸二乙酯三乙胺 作用下, 以 乙醇 为溶剂, 反应 6.0h, 生成 (S)-2-{2-[4-(6,7-Difluoro-quinoxalin-2-ylamino)-phenyl]-acetylamino}-pentanedioic acid
    参考文献:
    名称:
    Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-l-glutamates as analogues–homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity
    摘要:
    Among a new series of 26 4-(3-substituted-2-quinoxalylamino)phenylacetates and 4-(3-substituted-2-quinoxalylamino)-phenylacetyl-L-glutamates, eight were selected at NO for evaluation of their in vitro anticancer activity. The results obtained in comparison with the corresponding nor-compounds series seem to indicate that this type of homologation is not helpful. (C) 2002 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(01)01159-4
  • 作为产物:
    描述:
    参考文献:
    名称:
    Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-l-glutamates as analogues–homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity
    摘要:
    Among a new series of 26 4-(3-substituted-2-quinoxalylamino)phenylacetates and 4-(3-substituted-2-quinoxalylamino)-phenylacetyl-L-glutamates, eight were selected at NO for evaluation of their in vitro anticancer activity. The results obtained in comparison with the corresponding nor-compounds series seem to indicate that this type of homologation is not helpful. (C) 2002 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(01)01159-4
点击查看最新优质反应信息